Zimmer Biomet Holdings (ZBH) Capital Expenditures (2009 - 2026)

Zimmer Biomet Holdings' Capital Expenditures history runs 18 years deep, the most recent figure standing at $36.3 million for Q1 2026.

• On a quarterly basis, Capital Expenditures fell 18.61% year-over-year to $36.3 million in Q1 2026; TTM through Mar 2026 was $216.2 million, a 11.85% increase from a year earlier, with the FY2025 full-year figure at $224.5 million, up 10.16% from the prior year.
• Capital Expenditures slipped to $36.3 million in Q1 2026 per ZBH's latest filing, from $74.8 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $97.3 million in Q2 2023 and bottomed at $36.3 million in Q1 2026.
• The 5-year median for Capital Expenditures is $51.5 million (2024), against an average of $55.5 million.
• Across the five-year window, Capital Expenditures soared 137.9% in 2023 and plunged 47.21% in 2024, its largest moves.
• Year by year, Capital Expenditures stood at $63.4 million in 2022, then slipped by 0.95% to $62.8 million in 2023, then decreased by 17.99% to $51.5 million in 2024, then soared by 45.24% to $74.8 million in 2025, then plunged by 51.47% to $36.3 million in 2026.
• Per Business Quant, the three latest ZBH Capital Expenditures figures stand at $36.3 million (Q1 2026), $74.8 million (Q4 2025), and $55.0 million (Q3 2025).